Nearly half of cancer deaths due to smoking-attributable cancers
the ONA take:
Researchers from the American Cancer Society updated estimates of cancer-related deaths from smoking. The new numbers indicate an estimated 48.5% of the nearly 346,000 deaths from 12 cancers among adults 35 years and older were attributable to cigarette smoking.
The researchers used data from the 2011 National Health Interview Survey, the Cancer Prevention Study III, and the pooled contemporary cohort.
The results show that of an estimated 345,962 deaths, 167,805 were attributable to smoking cigarettes. Cancers of the lung, bronchus, and trachea and cancer of the larynx made up the largest proportion of smoking-attributable deaths: 80.2% and 76.6%, respectively.
In addition, approximately half of deaths from cancers of the oral cavity, esophagus, and urinary bladder were attributable to smoking.
The authors conclude that further progress in reducing cancer mortality will depend on more comprehensive tobacco control, including targeted cessation support.
An estimated 48.5% of the nearly 346,000 deaths from 12 cancers among adults 35 years and older were attributable to cigarette smoking.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|